Glendon E. French III - 01 Mar 2024 Form 4 Insider Report for Pulmonx Corp (LUNG)

Signature
/s/ Lauren Cristina, Attorney-in-Fact
Issuer symbol
LUNG
Transactions as of
01 Mar 2024
Net transactions value
-$63,003
Form type
4
Filing time
05 Mar 2024, 18:15:13 UTC
Previous filing
16 Feb 2024
Next filing
05 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Sale $10,772 -1,189 -0.11% $9.06 1,122,523 01 Mar 2024 Direct F1, F2
transaction LUNG Common Stock Sale $16,471 -1,818 -0.16% $9.06 1,120,705 01 Mar 2024 Direct F3
transaction LUNG Common Stock Sale $35,760 -3,947 -0.35% $9.06 1,116,758 01 Mar 2024 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021.
F2 Includes 2,368 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on February 21, 2024.
F3 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022.
F4 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.